134. Deputy Catherine Murphy asked the Minister for Health if he will outline the manner in which the National Centre for Pharmacoeconomics decides on the merits of making new drugs available for public patients in the State; if there are specific guidelines in place to ensure that public health concerns are taken fully into account and the decision is not purely an economic one; if he has any direct input into any stage of the decision making process; and if he will make a statement on the matter. [22458/13]

Summary

134. Deputy Catherine Murphy asked the Minister for Health if he will outline the manner in which the National Centre for Pharmacoeconomics decides on the merits of making new drugs available for public patients in the State; if there are specific guidelines in place to ensure that public health concerns are taken fully into account and the decision is not purely an economic one; if he has any direct input into any stage of the decision making process; and if he will make a statement on the matter. [22458/13]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Supply

  xml · EN · 14 May 2013

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.